[1] ZHANG L, WANG H D, ZHOU X M, et al. Role of mitochondrial calcium uniporter-mediated Ca2+ and iron accumulation in traumatic brain injury[J]. J Cellular Molecular Medi, 2019, 23(4): 2995-3009. doi:  10.1111/jcmm.14206
[2] MODI H R, MUSYAJU S, RATCLIFFE M, et al. Mitochondria-targeted antioxidant therapeutics for traumatic brain injury[J]. Antioxidants, 2024, 13(3): 303. doi:  10.3390/antiox13030303
[3] JIANG J Y, GAO G Y, FENG J F, et al. Traumatic brain injury in China[J]. Lancet Neurol, 2019, 18(3): 286-295. doi:  10.1016/S1474-4422(18)30469-1
[4] 韩亚进, 孙科, 潘卫民, 等. 1990—2023年中国创伤性颅脑损伤疾病负担与变化趋势分析[J]. 中国修复重建外科杂志, 2025, 39(11): 1388-1394.
[5] HACKENBERG K, UNTERBERG A. Schädel-Hirn-Trauma: Traumatic brain injury[J]. Nervenarzt, 2016, 87(2): 203-216.
[6] YONUTAS H M, VEKARIA H J, SULLIVAN P G. Mitochondrial specific therapeutic targets following brain injury[J]. Brain Res, 2016, 1640(Pt A): 77-93.
[7] SATCHELL M A, ZHANG X P, KOCHANEK P M, et al. A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3γ[J]. J Neurochem, 2003, 85(3): 697-708. doi:  10.1046/j.1471-4159.2003.01707.x
[8] SZCZESNY B, BRUNYANSZKI A, OLAH G, et al. Opposing roles of mitochondrial and nuclear PARP1 in the regulation of mitochondrial and nuclear DNA integrity: implications for the regulation of mitochondrial function[J]. Nucleic Acids Res, 2014, 42(21): 13161-13173. doi:  10.1093/nar/gku1089
[9] 皮如玉, 李佳蕊. PARP抑制剂在卵巢癌治疗中的研究进展[J]. 国际妇产科学杂志, 2016, 43(5): 515-518. doi:  10.3969/j.issn.2095-1264.2025.01.03
[10] 王莹颖, 刘文景, 宁瑶, 等. PARP抑制剂的作用机制和研究进展[J]. 中国新药杂志, 2018, 27(3): 306-313. doi:  10.3969/j.issn.1003-3734.2018.03.011
[11] 徐鹏程, 于鑫, 郭兆明, 等. 靶向线粒体的载体给药系统研究进展[J]. 内蒙古大学学报(自然科学版), 2017, 48(2): 219-224. doi:  10.13484/j.nmgdxxbzk.20170219
[12] SUKHANOVA E I, TRENDELEVA T A, ZVYAGILSKAYA R A. Interaction of yeast mitochondria with fatty acids and mitochondria-targeted lipophilic cations[J]. Biochemistry, 2010, 75(2): 139-144. doi:  10.1134/s0006297910020033
[13] MURPHY M P, SMITH R A J. Targeting antioxidants to mitochondria by conjugation to lipophilic cations[J]. Annu Rev Pharmacol Toxicol, 2007, 47: 629-656. doi:  10.1146/annurev.pharmtox.47.120505.105110
[14] LIU Y, HUANG R Q, HAN L, et al. Brain-targeting gene delivery and cellular internalization mechanisms for modified rabies virus glycoprotein RVG29 nanoparticles[J]. Biomaterials, 2009, 30(25): 4195-4202. doi:  10.1016/j.biomaterials.2009.02.051
[15] KRAINZ T, LAMADE A M, DU L N, et al. Synthesis and evaluation of a mitochondria-targeting poly(ADP-ribose)polymerase-1 inhibitor[J]. ACS Chem Biol, 2018, 13(10): 2868-2879. doi:  10.1021/acschembio.8b00423